Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Does the Forecast Indicate for the Viral Clearance Market From 2025 to 2029?
The expansion of the viral clearance marketplace has been quick in previous years, escalating from $0.82 billion in 2024 to $0.96 billion in 2025, maintaining a compound annual growth rate (CAGR) of 16.9%. The historical growth period could be connected to the surge in biopharmaceutical production, intensified regulatory focus on viral security, the widespread occurrence of chronic and infectious diseases, the growth in manufacturing of plasma-derived products, an increased tendency to outsource to Clinical Research Organizations (CROs) and Contract Development Manufacturing Organizations (CDMOs), and the wider acceptance of monoclonal antibodies and recombinant proteins.
The market size for viral clearance is set to witness exponential growth in the forthcoming years, ascending to a value of $1.77 billion in 2029 with a compound annual growth rate (CAGR) of 16.6%. This robust growth in the upcoming years can be linked to the escalating demand for cell and gene therapies, an accentuated emphasis on biosafety in biomanufacturing, intense regulations for validation requirements, the growth of biologics production facilities, an increase in outsourcing for viral safety testing, and the growing preference for single-use systems in bioprocessing. Future trends that are anticipated during this forecast period encompass the assimilation of high-throughput analytical technologies, accepting single-use systems, progression in the filtration and chromatography methods, advancements in continuous bioprocessing, and the proliferation of contract-based research and manufacturing services.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27444&type=smp
What Elements Are Contributing To Growth In The Viral Clearance Market?
The growing occurrence of chronic diseases worldwide is anticipated to promote the expansion of the viral clearance market. Chronic illnesses, which have a gradual onset and persist for extended periods, often necessitate continuous treatment or management. The global incidence of these diseases is on the rise, primarily due to increased life expectancy resulting from better healthcare and living conditions. This increase leads to a surge in age-related conditions like cardiovascular diseases, diabetes, arthritis, and cancer. Viral clearance plays a vital role in the production of biologics and gene therapies used for managing chronic diseases, ensuring their safety and efficacy. For example, it was reported by the Institute for Health Metrics and Evaluation, a US-based public health research institute, in June 2023, that diabetes had affected over five hundred million individuals worldwide. These figures are predicted to more than double, hitting 1.3 billion individuals by 2050. Thus, the escalating incidence of chronic diseases is fueling the viral clearance market’s growth.
Which Segments Are Detailed In The Global Viral Clearance Market Report?
The viral clearance market covered in this report is segmented
1) By Method: Viral Clearance Method, Viral Removal Method, Viral Inactivation Method, Viral Detection Method
2) By Application: Vaccines And Therapeutics, Blood And Blood Products, Cellular And Gene Therapy Products, Tissue And Tissue Products, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Other End Users
Subsegments:
1) By Viral Clearance Method: Downstream Processing, Filtration, Chromatography, Precipitation, Nanofiltration
2) By Viral Removal Method: Membrane Chromatography, Depth Filtration, Nanofiltration, Ultrafiltration, Protein A Affinity Chromatography
3) By Viral Inactivation Method: Solvent Detergent Method, Low pH Treatment, Heat Treatment (Pasteurization), UV-C Irradiation, Caprylate Treatment
4) By Viral Detection Method: PCR (Polymerase Chain Reaction), ELISA (Enzyme-Linked Immunosorbent Assay), Nucleic Acid Testing (NAT), Cell-Based Assays, Transmission Electron Microscopy (TEM)
Which Emerging Trends And Strategic Shifts Are Shaping The Viral Clearance Market?
Leading businesses in the viral clearance market are concentrating on a capacity expansion strategy, such as large-scale viral vector production facilities, to keep up with the increasing demand for gene therapies and biologics. Large-scale viral vector production sites refer to advanced bioproduction locations with the specialized ability to produce viral vectors used in cell and gene treatment, ensuring high purity, safety, and adherence to viral clearance guidelines. For instance, Thermo Fisher Scientific, a biotechnology firm based in the United States, inaugurated its new 300,000-square-foot commercial viral vector production facility in Plainville, Massachusetts in August 2022. This facility allows for fully integrated manufacturing, including viral clearance and analytical testing, doubling its worldwide capacity and aiding the swift and safe launch of gene therapies, vaccines, and next-generation biologics.
Who Are The Key Contributors To Growth In The Viral Clearance Market?
Major companies operating in the viral clearance market are F Hoffmann-La Roche Ltd., Merck Group, Thermo Fisher Scientific Inc., Asahi Kasei Corporation, SGS SA, Eurofins Scientific Inc., Lonza Group AG, WuXi AppTec, Catalent Biologics, Charles River Laboratories, Kedrion Biopharma, Nelson Labs, Pall Corporation, Sartorius AG, Syngene International, Microbac Laboratories, Creative Biolabs, Texcell SA, GTP Bioways, and Vironova AB.
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/viral-clearance-global-market-report
Which Region Is Projected To Lead The Viral Clearance Market By 2025?
North America was the largest region in the viral clearance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral clearance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27444&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model